Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

BACKGROUND: A considerable proportion of estrogen receptor (ER)-positive breast cancer recurs despite tamoxifen treatment, which is a serious problem commonly encountered in clinical practice. We tried to find novel prognostic markers in this subtype of breast cancer. METHODS: We performed array com...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Wonshik, Han, Mi-Ryung, Kang, Jason Jongho, Bae, Ji-Yeon, Lee, Ji Hyun, Bae, Young Ju, Lee, Jeong Eon, Shin, Hyuk-Jae, Hwang, Ki-Tae, Hwang, Sung-Eun, Kim, Sung-Won, Noh, Dong-Young
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459182/
https://www.ncbi.nlm.nih.gov/pubmed/16608533
http://dx.doi.org/10.1186/1471-2407-6-92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459182/
https://www.ncbi.nlm.nih.gov/pubmed/16608533
http://dx.doi.org/10.1186/1471-2407-6-92

Ejemplares similares